BsC in Biology (University San Luis Gonzaga Ica, Peru, 2003), MsC in Advanced Microbiology (University of Barcelona, 2010), MsC in AIDS (University of Barcelona, 2013) and PhD in Medicine (University of Barcelona, 2011). I am an Associate Professor at the University of Barcelona and Coordinator of the Research Line in Pneumonia of the Research Group on Management and Prevention of Infections, Interstitial and Tumoral Lung Diseases of the August Pi I Sunyer Institute of Biomedical Research (IDIBAPS). I have conducted research on the etiopathogenesis of pneumonia for over 12 years, starting with my PhD on Medicine at University of Barcelona on the microbial etiology of pneumonia. My first Postdoctoral Research Stay at the Respiratory Medicine Unit, General Hospital, Sestri Levante, Italy, under the supervision of Prof. Antonello Nicolini, the Director of the Unit, included work on polymicrobial pneumonia. My second Postdoctoral Research Stay at the Department of Pathophysiology and Transplantation at the University of Milan, under the direct supervision of Prof. Francesco Blasi, Head of the Cardiothoracic Unit, included work on severe pneumonia. I have obtained research funds as principal investigator (€ 213,000 accumulated funding as IP and €250,000 as IC) from competitive calls in Spain (Instituto de Salud Carlos III, Spanish Society of Pulmonology, and the Catalan Pulmonology Foundation) and from the European Respiratory Society to investigate  pneumonia, and I collaborate with several national and international research groups: the Spanish Working Group on Severe Pandemic Influenza A,  the Global Initiative methicillin-resistant Staphyloccus aureus pneumonia study group; the researchers of the Post-pandemic review of anti-Influenza Drug Effectiveness  Consortium, and the European Network for ICU-Related Respiratory Infections.

My current field of expertise is the study of the etiopathogenesis of pneumonia, and my future research aim is to characterize the immunological phenotypes of pneumonia and to investigate the usefulness of biomarkers to identify cardiovascular complications in severe influenza infection. I have authored 114 scientific publications (2,155 total citations; H-index: 26, and 66 total publications in the Q1), seven book chapters, and one book. My major achievements can be summarized in four main interconnected goals of fundamental interest and particularly due to their potential for change the clinical practice: Studying the immunological profile of pneumonia patients; Describing the microbiological features of pneumonia in different settings and the risk factors associated with antibiotic-resistant pathogens; Demonstrating that HIV patients with Legionella pneumonia should be managed in the same way as in people without HIV and that virologically suppressed HIV patients with pneumococcal pneumonia should be management as general population; Reporting the prevalence of sepsis in very old patients with pneumonia.

I have received the Extraordinary Doctoral Award from the University of Barcelona, the Fellow of the European Respiratory Society (FERS) award, and the Mentor award from the Spanish Society of Pneumology. The results of my research are likely to change clinical practices and will be incorporated into future clinical guidelines. In summary, the main goal of my research is to improve the knowledge and management of pneumonia.